New oncolytic virus shows improved effectiveness in preclinical testing
Thursday, October 27, 2011 - 16:01
in Biology & Nature
A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer.